Search

everythinglearnresearchcommunity

for

Search:↓

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

CBD can either reduce inflammation and not affect hair growth at low levels or inhibit hair growth at high levels.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Healthy mitochondria in skin cells are essential for proper hair growth and skin cell interaction in mice.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Histone H4, released by cells exposed to colchicine, can cause hair loss by inhibiting cell growth and enzyme activity.

Hair follicle melanocytes die during hair regression.

Researchers found a way to grow cashmere goat hair cells in a lab and discovered that certain conditions improve these cells' growth and characteristics.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Caffeine improves hair growth, thickness, and reduces shedding.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

The hair follicle is a great model for research to improve hair growth treatments.

Zinc supplements can resolve skin issues caused by zinc deficiency.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

A substance from hair follicle stem cells helps heal skin wounds in diabetic mice by promoting cell growth and preventing cell death.

Gambogic Amide helps maintain hair color and promotes hair growth.

Non-invasive methods can effectively diagnose and manage alopecia areata.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.